Skip to main content
Top
Published in:

Open Access 28-09-2024 | Antibiotic | RESEARCH

Neonatal and early infancy antibiotic exposure is associated with childhood atopic dermatitis, wheeze and asthma

Authors: Santeri Räty, Helena Ollila, Olli Turta, Anna Pärtty, Ville Peltola, Hanna Lagström, Johanna Lempainen, Samuli Rautava

Published in: European Journal of Pediatrics | Issue 12/2024

Login to get access

Abstract

Antibiotics are frequently administered in the neonatal period and early infancy. Little is known about the long-term health consequences of early life antibiotic exposure. The objective is to investigate the association between neonatal and early life (0–6 months) antibiotic treatment and the development of atopic dermatitis, asthma and the use of inhaled corticosteroid medication later in childhood. We analyzed data obtained from hospital records and national registers in a cohort of 11,255 children. The association between early antibiotic exposure and the outcomes were analyzed using logistic regression. Confounding factors were included in the model. Neonatal antibiotic therapy for confirmed infection was associated with childhood atopic dermatitis (adjusted odds ratio 1.49; 95% confidence interval 1.15–1.94). Antibiotic therapy by six months of age was more common in children developing atopic dermatitis (adjusted odds ratio 1.38; 95% confidence interval 1.15–1.64), asthma (adjusted odds ratio 1.56; 95% confidence interval 1.32- 1.85) and inhaled corticosteroid medication use (adjusted odds ratio 1.88; 95% confidence interval 1.66–2.13).
  Conclusions: Neonatal antibiotic therapy for confirmed or clinically diagnosed infection is associated with increased risk of atopic dermatitis later in childhood. Antibiotic treatment before six months of age is associated with atopic dermatitis, asthma and inhaled corticosteroid use.
What is known:
• The use of antibiotics early in life has been associated with an increased risk of developing atopic dermatitis or asthma.
• Confounding by indication or reverse causation may underlie the observed associations.
What is new:
• Our results demonstrate that neonatal antibiotic therapy for confirmed or clinically diagnosed infection was associated with increased risk of atopic dermatitis and antibiotic treatment before six months of age was associated with atopic dermatitis, asthma and inhaled corticosteroid use in analyses adjusted for confounding factors.
Appendix
Available only for authorised users
Literature
12.
go back to reference (2022) Asthma. Current care guidelines. Working group set up by the finnish medical society duodecim, the finnish respiratory society board, the finnish paediatric society, finnish society for pediatric allergy and the finnish society of clinical physiology. Helsinki: the finnish medical society duodecim. Available online at: www.kaypahoito.fi. Accessed 2 Sept 2024 (2022) Asthma. Current care guidelines. Working group set up by the finnish medical society duodecim, the finnish respiratory society board, the finnish paediatric society, finnish society for pediatric allergy and the finnish society of clinical physiology. Helsinki: the finnish medical society duodecim. Available online at: www.​kaypahoito.​fi. Accessed 2 Sept 2024
Metadata
Title
Neonatal and early infancy antibiotic exposure is associated with childhood atopic dermatitis, wheeze and asthma
Authors
Santeri Räty
Helena Ollila
Olli Turta
Anna Pärtty
Ville Peltola
Hanna Lagström
Johanna Lempainen
Samuli Rautava
Publication date
28-09-2024
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Pediatrics / Issue 12/2024
Print ISSN: 0340-6199
Electronic ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-024-05775-1

Keynote webinar | Spotlight on adolescent vaping

  • Live
  • Webinar | 29-01-2025 | 18:00 (CET)

Growing numbers of young people are using e-cigarettes, despite warnings of respiratory effects and addiction. How can doctors tackle the epidemic, and what health effects should you prepare to manage in your clinics?

Watch it live: Wednesday 29th January, 18:00-19:30 CET
 

Prof. Ann McNeill
Dr. Debbie Robson
Benji Horwell
Developed by: Springer Medicine
Join the webinar